Bee venom is used in pain management, skincare, allergy desensitization, and cancer research. Its primary active component, a peptide called melittin, makes up 40 to 60 percent of the venom and drives most of its biological effects, from reducing inflammation to destroying certain types of cells. While some applications have strong clinical backing, others remain experimental.
What’s Actually in Bee Venom
Bee venom is a complex mixture produced by female worker bees. Melittin is the dominant ingredient, but the venom also contains smaller peptides that calm nerve activity, enzymes that break down cell membranes and tissue barriers, amino acids, and volatile compounds. These components work together to create effects that range from triggering intense local inflammation (the familiar sting reaction) to suppressing pain signals and stimulating tissue repair.
Melittin itself has two distinct regions. One end is water-attracting and responsible for its ability to punch holes in cell membranes. The other end repels water and doesn’t cause cell damage on its own. This dual nature is what makes melittin both dangerous in large doses and potentially therapeutic in small, controlled ones.
Pain and Inflammation
The most established therapeutic use of bee venom is for pain relief, particularly in joint and nerve-related conditions. Bee venom acupuncture, where tiny amounts of purified venom are injected at specific points on the body, has been studied for osteoarthritis, complex regional pain syndrome, and chemotherapy-induced nerve pain. In a clinical trial for knee osteoarthritis registered on ClinicalTrials.gov, each injection consisted of just 100 micrograms of dried bee venom, a fraction of what a single sting delivers.
Animal studies have shown that bee venom reduces thermal hyperalgesia, the heightened sensitivity to heat that accompanies nerve damage. Research on chemotherapy-induced peripheral neuropathy, both in animal models and early clinical work, has supported the idea that bee venom can dampen the misfiring pain signals that make neuropathic conditions so difficult to treat. For complex regional pain syndrome, case studies have documented meaningful improvements, though large-scale trials are still limited.
One challenge with bee venom injections is that they hurt. Direct injection is the most effective delivery method because the venom is fully absorbed, but researchers have explored alternatives. Bee venom delivered through ultrasound-assisted gel (phonophoresis) improved pain scores and range of motion for delayed-onset muscle soreness in one randomized controlled trial. Topical ointments, by contrast, tend to underperform because the venom’s large molecules struggle to penetrate skin on their own.
Skincare and Anti-Aging
Bee venom has become a popular ingredient in high-end skincare, marketed as a natural alternative to injectable fillers. The science behind this is relatively straightforward: when applied topically, bee venom stimulates collagen production. In wounded mice treated with bee venom, researchers observed increased collagen protein synthesis, likely driven by faster proliferation and migration of skin cells called keratinocytes.
A human study on bee venom facial serum used a concentration of just 0.006% bee venom, mixed into a water-based formula with standard cosmetic ingredients. At that tiny concentration, the venom appears to trigger a mild micro-inflammation that prompts the skin to repair itself, thickening the epidermis and reducing the appearance of fine lines. The logic mirrors what happens with other controlled-irritation treatments like retinoids: a small amount of stress signals the skin to rebuild.
Cancer Research
Some of the most striking findings about bee venom come from oncology labs, though none have yet translated into approved cancer treatments. Melittin has demonstrated the ability to kill cancer cells across a remarkably wide range of tumor types, including melanoma, non-small-cell lung cancer, glioblastoma, leukemia, and ovarian, cervical, and pancreatic cancers. Notably, it tends to be more toxic to cancer cells than to normal cells.
A 2020 study published in Nature’s npj Precision Oncology showed that honeybee venom and melittin suppressed the activation of two growth factor receptors, EGFR and HER2, that fuel aggressive breast cancers. This is significant because HER2-enriched and triple-negative breast cancers are among the hardest to treat. The researchers also found that a positively charged section at one end of the melittin molecule is what allows it to latch onto and disrupt cancer cell membranes. By engineering an additional targeting sequence onto the peptide, they were able to improve its precision, directing it more selectively toward malignant cells while sparing healthy tissue.
Perhaps most promising, melittin appears to enhance the effectiveness of existing chemotherapy drugs. When combined with docetaxel in a mouse breast tumor model, melittin improved tumor suppression beyond what either treatment achieved alone. Similar synergistic effects have been reported with cisplatin in cervical and laryngeal cancers. These findings suggest bee venom components could eventually serve as combination therapy agents rather than standalone treatments.
Allergy Desensitization
Venom immunotherapy is the one bee venom application with decades of mainstream medical use. For people who have experienced severe allergic reactions to bee stings, gradually increasing doses of purified venom can retrain the immune system to tolerate it. This is standard practice in allergy clinics worldwide and is distinct from the alternative therapy uses described above.
The need for this treatment is real. Among beekeepers, who face repeated exposure, the estimated lifetime prevalence of systemic allergic reactions to bee venom is about 23.7%. Roughly 6% of beekeepers report severe reactions (grades III through IV), which can include difficulty breathing, a dangerous drop in blood pressure, or loss of consciousness.
How It’s Administered
Bee venom reaches the body through several routes, each suited to different purposes. Direct stinging, where a live bee is placed on the skin and allowed to sting, is the oldest and cheapest method. It delivers the venom in its freshest, most complete form but offers no control over dosage.
Bee venom acupuncture uses purified, measured venom injected with a needle at specific body points. This is the most common method in clinical research and allows precise dosing. Subcutaneous injection, where venom is delivered just under the skin without targeting acupuncture points, is another option used in both human and veterinary medicine.
For people who want the benefits without needles, phonophoresis (ultrasound-enhanced gel delivery) offers a middle ground. It pushes venom molecules through the skin barrier more effectively than a simple cream. Standard topical products like ointments and serums work for cosmetic purposes at very low concentrations but are generally insufficient for pain or inflammatory conditions.
Risks and Safety Concerns
Bee venom is not benign. The same biological activity that makes it therapeutic also makes it capable of triggering serious adverse reactions. Allergic responses are the primary concern, ranging from localized swelling to full anaphylaxis. Even people who have previously tolerated bee stings can develop sensitization over time, meaning repeated exposure through therapy could increase allergy risk rather than decrease it.
Case reports from a systematic review in PLOS ONE documented kidney damage (nephrotic syndrome) in a 28-year-old woman after bee venom acupuncture, toxic pulmonary edema in a 51-year-old man with high blood pressure, and reactivation of hepatitis B complicated by kidney problems in a 47-year-old man undergoing venom immunotherapy. These are rare events, but they illustrate that bee venom can stress the kidneys, liver, and cardiovascular system, particularly in people with pre-existing conditions.
Anyone with a known bee venom allergy, kidney disease, liver disease, or cardiovascular instability faces elevated risk. The lack of standardized dosing protocols across practitioners, especially in alternative medicine settings, adds another layer of unpredictability to treatment safety.